11 min listen
AHA Late-Breaker: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
AHA Late-Breaker: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results
FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
ratings:
Length:
10 minutes
Released:
Jan 10, 2023
Format:
Podcast episode
Description
A new study examined a very common clinical question of which loop diuretic or water pill is better in patients living with heart failure - torsemide or furosemide? Prior studies suggested that torsemide might be better than furosemide but they had never been compared head-to-head in a large clinical trial. The TRANSFORM-HF trial compared these 2 therapies against each other. In this interview, Robert J. Mentz MD and Laxmi Mehta MD, FACC discuss the primary findings of AHA Late-Breaker: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
Released:
Jan 10, 2023
Format:
Podcast episode
Titles in the series (100)
ACCEL Lite: STRENGTH Trial: High-Dose Omega-3 Fatty Acids vs. Corn Oil: The benefits and risks of fish oil derivatives remain controversial. STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) showed no benefits from administration... by ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research